1. Extract from spent hop (Humulus lupulus L.) reduces blood platelet aggregation and improves anticoagulant activity of human endothelial cells in vitro
- Author
-
Marcin Rozalski, Cezary Watala, Jacek Golanski, Tomasz Przygodzki, Jan Oszmiański, Dorota Sosnowska, Magdalena Boncler, and Boguslawa Luzak
- Subjects
0301 basic medicine ,Humulus lupulus ,Endothelium ,Spent hops ,Medicine (miscellaneous) ,030204 cardiovascular system & hematology ,Pharmacology ,Placebo ,Hop (networking) ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Platelet ,TX341-641 ,chemistry.chemical_classification ,CD39 ,Nutrition and Dietetics ,biology ,Chemistry ,Nutrition. Foods and food supply ,Blood platelet ,Glycoside ,Cardiovascular disorders ,biology.organism_classification ,In vitro ,030104 developmental biology ,medicine.anatomical_structure ,Proanthocyanidin ,Biochemistry ,Humulus lupulus L ,Food Science - Abstract
Spent hop extract (SHE) is hypothesized to possess multifaceted anticoagulant effect and to reduce platelet reactivity in a direct manner and to improve the antiplatelet action of endothelium. The results demonstrated that SHE, rich in flavanols (50% of total phenolic compounds), hydroxycinnamic acids, proanthocyanidin oligomers, flavan-3-ol monomers, and flavonol glycosides, inhibited ADP-induced platelet aggregation up to 11% for 7.5 µg/ml or up to 23% for 15 µg/ml, P 0.05. Additionally, SHE ameliorated anticoagulant activity of human endothelial cells to significantly reduce platelet reactivity. This effect could be related to the increased expression/activity of the ecto-ADPase (CD39). ADP-induced platelet reactivity was reduced in the case of platelets incubated with the extract-treated endothelial cells compared to the untreated cells. Diabetic rats fed with SHE demonstrated longer survival time than the group treated with placebo. In conclusion, our study provided evidence for a potential beneficial role of SHE in the regulation of platelet and endothelial function.
- Published
- 2016